{"id":"W7093121128","doi":"","title":"DP114 | ISATUXIMAB, BORTEZOMIB, LENALIDOMIDE, DEXAMETHASONE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MYELOMA AND PLASMACYTOMAS: IMROZ SUBGROUP ANALYSIS","year":2025,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Subgroup analysis; Adverse effect; Hazard ratio; Clinical endpoint; Multiple myeloma; Common Terminology Criteria for Adverse Events","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001432193,0.0008628314,0.001966711,0.0009305957,0.0002130254,0.0008187614,0.0005472046,0.0004578734,0.004715701],"category_scores_gemma":[0.001685195,0.0002607435,0.005733927,0.0009159938,0.0001798045,0.0003845473,0.0005334591,0.0006071065,0.0003828948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005906037,"about_ca_system_score_gemma":0.0007190168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001228032,"about_ca_topic_score_gemma":0.00344955,"domain_scores_codex":[0.998763,0.0004022803,0.0002154063,0.0002807406,0.0001784121,0.0001602347],"domain_scores_gemma":[0.999529,0.0001437511,0.0001172287,0.00009172856,0.00004410555,0.00007419782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4849335,0.0009740207,0.2628541,0.003002194,0.08314253,0.0007948782,0.0001802786,0.002301171,0.007312583,0.0005425703,0.008434484,0.1455276],"study_design_scores_gemma":[0.1187188,0.04332642,0.6559526,0.0005650521,0.1321317,0.00231036,0.0007244806,0.008184375,0.004101582,0.002551392,0.03123339,0.0001999181],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9719582,0.01671324,0.001082218,0.0005023926,0.0001841963,0.0008238649,0.006326842,0.00005369782,0.002355197],"genre_scores_gemma":[0.992841,0.001062873,0.0004293429,0.0002422874,0.0001551947,0.0003771067,0.003883138,0.00001189619,0.0009971351],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004715701,"threshold_uncertainty_score":0.01577562,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09302658097092445,"score_gpt":0.4924053224935804,"score_spread":0.399378741522656,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}